Fresenius Medical Care AG (FMS) Raw Materials (2009 - 2025)

Fresenius Medical Care AG's Raw Materials history runs 17 years deep, the most recent figure standing at $383.3 million for Q4 2025.

• In Q4 2025, Raw Materials rose 4.18% year-over-year to $383.3 million; the TTM figure through Dec 2025 stood at $383.3 million (up 4.18% YoY), while the FY2025 annual figure was $383.3 million, up 4.18% from the prior year.
• Raw Materials was $383.3 million for Q4 2025 at Fresenius Medical Care AG, up from $367.9 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $517.2 million in Q4 2021 to a low of $313.2 million in Q4 2022.
• Historically, Raw Materials has averaged $394.2 million across 5 years, with a median of $383.3 million in 2025.
• The sharpest annual moves came in 2021 and 2022: Raw Materials surged 86.62% in 2021, then slumped 39.44% in 2022.
• A 5-year view of Raw Materials shows it stood at $517.2 million in 2021, then plunged by 39.44% to $313.2 million in 2022, then increased by 24.29% to $389.3 million in 2023, then slipped by 5.48% to $367.9 million in 2024, then grew by 4.18% to $383.3 million in 2025.
• The last three Raw Materials figures came in at $383.3 million (Q4 2025), $367.9 million (Q4 2024), and $389.3 million (Q4 2023), per Business Quant data.